Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
The United Laboratories International Holdings Ltd (United Lab) manufactures and sells pharmaceutical products, such as oral antibiotics, antimicrobial for injection, diabetes drugs, anti-cold, cough medicine, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, vacant gelatin capsule, APIs, intermediates, and others.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s research and development (R&D) efforts focus on optimizing offerings of insulin products, and preparing those for approval, also researching a variety of biological preparations, including insulin aspart injection, liraglutide injection, insulin degludec injection, insulin degludec-insulin aspart mixed injection, and insulin degludecliraglutide injection and other syndromes to gradually put in the market for benefit of diabetics and other patients. The company has 18 new Class 1 drug projects in the clinical stage and has made progress in the R&D of new drugs, product registration and approval, and consistency evaluation of generic drugs. The company is also actively planning and promoting the overseas licensing of new drug projects. The R&D units of the company include multiple platforms such as biological research and development, chemical drug research and development, innovative drug research and development, animal healthcare research and development clinical research center, and external cooperation. The company also continues to focus on the fields of autoimmune disease and internal secretion. The company is developing 45 new human drug products, including 22 Class 1 new drugs targeting endocrinology, metabolism, autoimmunity, ophthalmology, and anti-infectives. Additionally, 59 new animal healthcare products are in development across pets, livestock, poultry, and aquaculture. In FY2024, the company spent CNY890.7 million on its R&D activities which as a percentage of revenue stood at 6.5% and grew 17.6% YoY.
Business Segments
Overview
Provides medicines including, semi-synthetic penicillins type, Cephalosporins type, lactamase inhibitors type, Carbapenems, and Insulin API. Believes that optimizing price of the segment's products is a major growth driver.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides medicines including, semi-synthetic penicillin antibiotics tablets, lactamase inhibitors antibiotics, cephalosporin antibiotics, carbapenems antibiotics, Insulin products and others, including capsule casings. Deems insulin series as to be the main driving force of the company growth.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides intermediate products, such as 6-Aminopenicillin Acid (6-APA), Penicillin G Potassium First Crystal and T-Octylammonium Clavulanate. Believes that optimizing production process, and diversification of products are major growth drivers.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
- Europe
- India
- Middle East
- Other Asian Regions
- Other Regions
- PRC, Including Hong Kong (Country Of Domicile)
- South America
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer